{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:33:53Z","timestamp":1759581233511,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10067-024-06925-4","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T10:01:51Z","timestamp":1714384911000},"page":"2021-2026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-8996","authenticated-orcid":false,"given":"Seher","family":"Sener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Aliyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi Deniz","family":"Batu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Balik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yagmur","family":"Bayindir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel","family":"Cam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"1","key":"6925_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J 19(1):135. https:\/\/doi.org\/10.1186\/s12969-021-00629-8","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"6925_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"2","key":"6925_CR3","first-page":"157","volume":"55","author":"GO Yener","year":"2021","unstructured":"Yener GO, Tekin ZE, Giri\u015fgen \u0130, \u00c7etin EN, Akda\u011f B, Y\u00fcksel S (2021) Juvenile idiopathic arthritis in a center in the Western Anatolia region in Turkey. Turk Arch Pediatr 55(2):157\u2013165","journal-title":"Turk Arch Pediatr"},{"issue":"12","key":"6925_CR4","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1007\/s10067-022-06327-4","volume":"41","author":"F Ayd\u0131n","year":"2022","unstructured":"Ayd\u0131n F, \u00c7akar N, Kurt T, \u00c7elikel Acar B, \u00c7elikel E, \u00d6z\u00e7akar ZB et al (2022) What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis? Clin Rheumatol 41(12):3791\u20133796","journal-title":"Clin Rheumatol"},{"key":"6925_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/978-981-15-8323-0_24","volume-title":"Skills in rheumatology","author":"R Abdwani","year":"2021","unstructured":"Abdwani R (2021) Pediatric rheumatology. In: Almoallim H, Cheikh M (eds) Skills in rheumatology. Springer Singapore, Singapore, pp 501\u2013518"},{"issue":"2","key":"6925_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opur \u00d6 (2017) Juvenile idiopathic arthritis. Balkan Med J 34(2):90\u2013101","journal-title":"Balkan Med J"},{"issue":"10072","key":"6925_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli A, Dav\u00ec S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP et al (2017) Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Lancet 389(10072):909\u2013916. https:\/\/doi.org\/10.1016\/S0140-6736(17)30065-X","journal-title":"Lancet"},{"issue":"4","key":"6925_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/acr.24853","volume":"74","author":"KB Onel","year":"2022","unstructured":"Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST et al (2022) 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 74(4):521\u2013537","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"6925_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","volume":"16","author":"G Ferrara","year":"2018","unstructured":"Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G et al (2018) Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol Online J 16(1):46. https:\/\/doi.org\/10.1186\/s12969-018-0255-8","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"6925_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11882-013-0351-2","volume":"13","author":"JG Harris","year":"2013","unstructured":"Harris JG, Kessler EA, Verbsky JW (2013) Update on the treatment of juvenile idiopathic arthritis. Curr Allergy Asthma Rep 13(4):337\u2013346","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"6925_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14744\/nci.2019.57873","volume":"7","author":"M Cakan","year":"2020","unstructured":"Cakan M, Ayaz NA, Karadag SG, Tanatar A (2020) The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis. North Clin Istanb 7(2):118\u2013123. https:\/\/doi.org\/10.14744\/nci.2019.57873","journal-title":"North Clin Istanb"},{"issue":"2","key":"6925_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R et al (2019) Toward new classification criteria for juvenile idiopathic arthritis: first steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol 46(2):190\u2013197","journal-title":"J Rheumatol"},{"issue":"11","key":"6925_CR13","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31(11):2290\u20132294","journal-title":"J Rheumatol"},{"issue":"5","key":"6925_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61(5):658\u2013666. https:\/\/doi.org\/10.1002\/art.24516","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6925_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12969-018-0260-y","volume":"16","author":"DJ Lovell","year":"2018","unstructured":"Lovell DJ, Dare JA, Francis-Sedlak M, Ball J, LaMoreaux BD, Von Scheven E et al (2018) A 6-month, multicenter, open-label study of fixed dose naproxen\/esomeprazole in adolescent patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 16(1):41. https:\/\/doi.org\/10.1186\/s12969-018-0260-y","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"6925_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1053\/berh.2002.0234","volume":"16","author":"KJ Murray","year":"2002","unstructured":"Murray KJ, Lovell DJ (2002) Advanced therapy for juvenile arthritis. Best Pract Res Clin Rheumatol 16(3):361\u2013378","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"6925_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-022-00682-x","volume":"20","author":"LR Grazziotin","year":"2022","unstructured":"Grazziotin LR, Currie G, Twilt M, Ijzerman MJ, Kip MMA, Koffijberg H et al (2022) Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study. Pediatr Rheumatol Online J 20(1):25. https:\/\/doi.org\/10.1186\/s12969-022-00682-x","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"6925_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF et al (2012) Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol 39(9):1867\u20131874","journal-title":"J Rheumatol"},{"issue":"8","key":"6925_CR19","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/1529-0131(200008)43:8<1858::AID-ANR23>3.0.CO;2-A","volume":"43","author":"S Guillaume","year":"2000","unstructured":"Guillaume S, Prieur A-M, Coste J, Job-Deslandre C (2000) Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 43(8):1858\u20131865. https:\/\/doi.org\/10.1002\/1529-0131(200008)43:8%3c1858::AID-ANR23%3e3.0.CO;2-A","journal-title":"Arthritis Rheum"},{"issue":"9","key":"6925_CR20","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/eji.201546092","volume":"46","author":"JF Swart","year":"2016","unstructured":"Swart JF, de Roock S, Prakken BJ (2016) Understanding inflammation in juvenile idiopathic arthritis: how immune biomarkers guide clinical strategies in the systemic onset subtype. Eur J Immunol 46(9):2068\u20132077. https:\/\/doi.org\/10.1002\/eji.201546092","journal-title":"Eur J Immunol"},{"issue":"1","key":"6925_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12969-021-00522-4","volume":"19","author":"A Raab","year":"2021","unstructured":"Raab A, Kallinich T, Huscher D, Foeldvari I, Weller-Heinemann F, Dressler F et al (2021) Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry. Pediatr Rheumatol Online J 19(1):41. https:\/\/doi.org\/10.1186\/s12969-021-00522-4","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"6925_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.semarthrit.2016.06.001","volume":"46","author":"R Davies","year":"2016","unstructured":"Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SEA, Davidson JE et al (2016) Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): analysis from the UK Childhood Arthritis Prospective Study (CAPS). Semin Arthritis Rheum 46(2):190\u2013195","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"6925_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/ard.2009.120840","volume":"69","author":"I Vilca","year":"2010","unstructured":"Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B et al (2010) Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis 69(8):1479\u20131483","journal-title":"Ann Rheum Dis"},{"key":"6925_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1546-0096-12-51","volume":"12","author":"EH van Dijkhuizen","year":"2014","unstructured":"van Dijkhuizen EH, Wulffraat NM (2014) Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. Pediatr Rheumatol Online J 12:51. https:\/\/doi.org\/10.1186\/1546-0096-12-51","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06925-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:05:42Z","timestamp":1716393942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06925-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6925"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06925-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}